Getinge (OTCMKTS:GNGBY – Get Free Report) and Cigna Group (NYSE:CI – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations.
Profitability
This table compares Getinge and Cigna Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Getinge | 8.20% | 11.55% | 6.15% |
| Cigna Group | 2.27% | 19.75% | 5.34% |
Earnings & Valuation
This table compares Getinge and Cigna Group”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Getinge | $3.57 billion | 2.14 | $230.87 million | $1.10 | 25.51 |
| Cigna Group | $274.90 billion | 0.28 | $5.96 billion | $24.17 | 12.21 |
Cigna Group has higher revenue and earnings than Getinge. Cigna Group is trading at a lower price-to-earnings ratio than Getinge, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent ratings and recommmendations for Getinge and Cigna Group, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Getinge | 0 | 4 | 0 | 0 | 2.00 |
| Cigna Group | 0 | 8 | 14 | 0 | 2.64 |
Cigna Group has a consensus price target of $335.70, indicating a potential upside of 13.77%. Given Cigna Group’s stronger consensus rating and higher probable upside, analysts plainly believe Cigna Group is more favorable than Getinge.
Volatility & Risk
Getinge has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, Cigna Group has a beta of 0.25, suggesting that its share price is 75% less volatile than the S&P 500.
Dividends
Getinge pays an annual dividend of $0.29 per share and has a dividend yield of 1.0%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.1%. Getinge pays out 26.4% of its earnings in the form of a dividend. Cigna Group pays out 25.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Institutional and Insider Ownership
87.0% of Cigna Group shares are held by institutional investors. 0.6% of Cigna Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
Cigna Group beats Getinge on 12 of the 17 factors compared between the two stocks.
About Getinge
-logo-1200x675.png?v=20241011142232){kind=logo}
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
About Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.
